119th Congress · House bill · Last action Jun 8, 2026
H.R. 9190In Committee
To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
Sponsor: Rep. Harshbarger, Diana [R-TN-1] (R-TN)1 cosponsorIntroduced Jun 8, 2026
✆
In plain English
A plain-English summary will be generated the next time this page is viewed by an admin.
Where it is in the process
✓
Introduced
Jun 8
✓
House committee
Jun 8
3
House floor
-
4
Senate
-
5
Signed
-
What happens next: Sits in committee. Needs a markup or favorable report to advance to the House floor.
Sponsor
DR
Cosponsors (1)
AR
All Republican.
Activity timeline
Jun 8
2d ago
2d ago
Referred to the House Committee on Energy and Commerce.
Jun 8
2d ago
2d ago
Introduced in House
Jun 8
2d ago
2d ago
Introduced in House
Read the bill text
Official text via Congress.gov. Opens in a new tab.
Full action log
All 3 recorded actions since introduction · Source: Congress.gov
Jun 8
HOUSEReferred to the House Committee on Energy and Commerce.
Jun 8
Introduced in House
Jun 8
Introduced in House
All 1 cosponsor
0 Democrats · 1 Republican
Republicans (1)
Biggs, AndyAZ-05
In the news
Track this bill
Get an alert when it moves to the next stage or gets a vote.